PEPFAR 中的计划科学:实现可持续艾滋病毒防治的途径。

IF 4.6 1区 医学 Q2 IMMUNOLOGY Journal of the International AIDS Society Pub Date : 2024-07-10 DOI:10.1002/jia2.26244
Michael J. A. Reid, Rebecca Bunnell, Emily Kainne Dokubo, John Nkengasong
{"title":"PEPFAR 中的计划科学:实现可持续艾滋病毒防治的途径。","authors":"Michael J. A. Reid,&nbsp;Rebecca Bunnell,&nbsp;Emily Kainne Dokubo,&nbsp;John Nkengasong","doi":"10.1002/jia2.26244","DOIUrl":null,"url":null,"abstract":"<p>Since its inception, the President's Emergency Plan For AIDS Relief (PEPFAR) has had an unprecedented impact on the global HIV epidemic. In the past 20 years, PEPFAR has saved more than 25 million lives, supporting over 20 million people with life-saving treatment across 55 countries [<span>1</span>]. From the beginning, its programmes have relied on the best scientific insights and biomedical discoveries to advance the strategic HIV agenda. Moving forward, PEPFAR faces numerous important challenges in supporting partner countries to achieve the UNAIDS targets of ensuring that 95% of people with HIV know their status, 95% of those are on treatment and 95% of those are virologically suppressed [<span>2</span>], and achieving its goal of ending the HIV pandemic as a public health threat by 2030. As such, it is important to consider how Programme Science—<i>an approach that emphasizes the need for context-specific evidence and knowledge generated on an ongoing basis, to inform the timely and strategic programmatic decisions</i> [<span>3, 4</span>]—can help ensure that PEPFAR programmes implement the right set of context-specific interventions to achieve and sustain the changes essential for HIV prevention and treatment outcomes. In this paper, we detail (1) the evolving challenges and opportunities PEPFAR faces in achieving 95-95-95, (2) how <i>Programme Science</i> can be strategically applied to overcome these challenges, and (3) the necessary adaptations needed to sustain HIV programmes, informed by the best, contextually relevant science.</p><p>As PEPFAR and its partners intensify efforts to achieve the UNAIDS targets and sustain the progress achieved, they face a range of complex and urgent health challenges. Addressing these challenges requires a Programme Science approach that is responsive to diverse real-world contexts—be they geographical, organizational or sociological [<span>5</span>].</p><p>One of the most urgent challenges PEPFAR programmes face is reaching those populations that are not effectively covered by existing services. This is especially true in many countries with high HIV burden, where there is a pressing and urgent need to devise innovative approaches to engage adolescents and young women who are at inordinate risk of HIV acquisition. Equally important is the provision of targeted interventions for specific key and priority groups like men who have sex with men and female sex workers, who often face significant barriers in accessing health services due to stigma, discrimination, and legal and human rights issues.</p><p>Another critical area of focus is supporting continuity of care for people living with HIV who have been linked to HIV services. Across PEPFAR programmes, over 450,000 persons experienced interruptions in treatment at some point in the third quarter of 2023 [<span>6</span>]. As such, supporting clients to stay engaged in lifelong care necessitates the identification and implementation of a tailored mix of biomedical, behavioural and structural interventions to ensure the continued provision and uptake of HIV treatment services. These interventions must be adaptable to suit the diverse needs of different populations in various locations.</p><p>Additionally, HIV programme must address the system-level challenges necessary to ensure that existing HIV services have an enduring impact and are optimally integrated into government-run programmes. As such, programmes must determine how to strengthen health systems so that they meet the individualized needs of clients with co-morbid diseases like hypertension [<span>7</span>], while also working with partner governments to determine opportunities for synergy and integration of HIV services into primary care systems.</p><p>Advancing PEPFAR's commitment to health equity while determining how and where to deploy new biomedical tools also raises a unique set of Programme Science questions [<span>8, 9</span>]. Decisions about the deployment of tools like long-acting HIV prevention and treatment must include consideration of context-specific factors, including end-user preferences [<span>10</span>], service delivery infrastructure [<span>11</span>] and resource availability.</p><p>Faced with these different and diverse challenges and opportunities, the new PEPFAR five-year strategic plan calls for an integration of science directly into programme planning and execution. Moreover, it will require a dynamic approach to how scientific insights are derived directly from programme experiences rather than only translating research into policy [<span>12</span>]. In the past, PEPFAR's policy decisions have often been guided by applying proven strategies from one context to another and leveraging existing hypothesis-driven science to inform planning, applying insights from science to policy and programmes. Notable examples include the introduction of the “Treatment as Prevention” strategy [<span>13</span>] and scaling pre-exposure prophylaxis interventions [<span>14</span>]. Policies for both were developed based on a substantial body of evidence that pre-existed policy formulation. However, this approach relied on scientific evidence being readily available to answer PEPFAR's strategic questions [<span>15</span>].</p><p>To realize the goals outlined in PEPFAR's strategic plan requires a shift in how programmes inform science and how and when science is used to shape its programmes. It demands that HIV programmes play a primary role in identifying how science is leveraged to close gaps in HIV service provision and to determine how best to scale new integrated service delivery models or potentially transformative biomedical tools. The focus needs to be on generating insights relevant to specific contexts that are also generalizable to different settings while prioritizing health equity.</p><p>Moving forward, PEPFAR is planning future initiatives across supported countries and regions to contribute to Programme Science, while also encouraging others working on the HIV response to expand their contributions to Programme Science too. PEPFAR's upcoming Country Operational Planning Guidance will highlight the importance of Programme Science for PEPFAR-supported country and regional programmes to prioritize in their operational planning process, aimed at addressing strategic priorities and programmatic gaps specific to each country or region. Incorporating Programme Science into operational planning, PEPFAR can better address identified gaps in knowledge and practice, ensuring that interventions are both scientifically grounded, pragmatically viable for diverse global contexts and responsive to local strategic priorities.</p><p>A critical next step involves empowering HIV programmes in each country in partnership with Ministries of Health, National Public Health Institutions, local academic partners and community leadership to identify the gaps where Programme Science can help ensure that evidence informs programmes on the timeline and at the scale necessary to drive impact. Creating the capacity to use Programme Science to inform strategic planning and resource allocation can ensure that programmes are continually responsive to the evolution of the HIV pandemic and that the needed biomedical and clinical tools, as well as essential resources, are available. Zambia offers a useful example of how this can work; a data hub run by the Ministry of Health with technical and limited financial support from PEPFAR is using rigorous analytic approaches to interrogate programme data to understand how and where programme improvements are likely to be most impactful. The Zambia example also illustrates how embedding Programme Science into how PEPFAR country programmes operate can also help advance PEPFAR's commitment to sustainable development, strengthened public health systems and transformative partnerships [<span>16</span>]. This approach not only addresses current challenges but also lays the groundwork for long-term success, ensuring that programmes continue to prioritize equity and impact.</p><p>As PEPFAR enters a new phase in its response to the HIV pandemic, it is important to ensure that policies and strategies are both evidence-based and tailored to the unique challenges of different communities and regions. As such, PEPFAR is committed to taking necessary steps to ensure that HIV programmes are empowered and have the capacity to undertake the kinds of analyses necessary for Programme Science to lead to programme improvement. We are explicitly designing new processes and mechanisms into our funding and policy guidance that foster the enabling environment for science and innovation necessary to accelerate progress. These changes can ensure that each country realizes the goal of 95-95-95 and that PEPFAR programmes continue to adapt to the evolving pandemic while also empowering the relevant local stakeholders to take the lead in using science to improve programmes.</p><p>The authors declare no competing interests.</p><p>RB and MJAR conceived of the presented idea. The first draft was written by MJAR, and all other authors revised and edited subsequent drafts. All authors reviewed the final, submitted draft.</p>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233845/pdf/","citationCount":"0","resultStr":"{\"title\":\"Programme Science in PEPFAR: a pathway to a sustainable HIV response\",\"authors\":\"Michael J. A. Reid,&nbsp;Rebecca Bunnell,&nbsp;Emily Kainne Dokubo,&nbsp;John Nkengasong\",\"doi\":\"10.1002/jia2.26244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Since its inception, the President's Emergency Plan For AIDS Relief (PEPFAR) has had an unprecedented impact on the global HIV epidemic. In the past 20 years, PEPFAR has saved more than 25 million lives, supporting over 20 million people with life-saving treatment across 55 countries [<span>1</span>]. From the beginning, its programmes have relied on the best scientific insights and biomedical discoveries to advance the strategic HIV agenda. Moving forward, PEPFAR faces numerous important challenges in supporting partner countries to achieve the UNAIDS targets of ensuring that 95% of people with HIV know their status, 95% of those are on treatment and 95% of those are virologically suppressed [<span>2</span>], and achieving its goal of ending the HIV pandemic as a public health threat by 2030. As such, it is important to consider how Programme Science—<i>an approach that emphasizes the need for context-specific evidence and knowledge generated on an ongoing basis, to inform the timely and strategic programmatic decisions</i> [<span>3, 4</span>]—can help ensure that PEPFAR programmes implement the right set of context-specific interventions to achieve and sustain the changes essential for HIV prevention and treatment outcomes. In this paper, we detail (1) the evolving challenges and opportunities PEPFAR faces in achieving 95-95-95, (2) how <i>Programme Science</i> can be strategically applied to overcome these challenges, and (3) the necessary adaptations needed to sustain HIV programmes, informed by the best, contextually relevant science.</p><p>As PEPFAR and its partners intensify efforts to achieve the UNAIDS targets and sustain the progress achieved, they face a range of complex and urgent health challenges. Addressing these challenges requires a Programme Science approach that is responsive to diverse real-world contexts—be they geographical, organizational or sociological [<span>5</span>].</p><p>One of the most urgent challenges PEPFAR programmes face is reaching those populations that are not effectively covered by existing services. This is especially true in many countries with high HIV burden, where there is a pressing and urgent need to devise innovative approaches to engage adolescents and young women who are at inordinate risk of HIV acquisition. Equally important is the provision of targeted interventions for specific key and priority groups like men who have sex with men and female sex workers, who often face significant barriers in accessing health services due to stigma, discrimination, and legal and human rights issues.</p><p>Another critical area of focus is supporting continuity of care for people living with HIV who have been linked to HIV services. Across PEPFAR programmes, over 450,000 persons experienced interruptions in treatment at some point in the third quarter of 2023 [<span>6</span>]. As such, supporting clients to stay engaged in lifelong care necessitates the identification and implementation of a tailored mix of biomedical, behavioural and structural interventions to ensure the continued provision and uptake of HIV treatment services. These interventions must be adaptable to suit the diverse needs of different populations in various locations.</p><p>Additionally, HIV programme must address the system-level challenges necessary to ensure that existing HIV services have an enduring impact and are optimally integrated into government-run programmes. As such, programmes must determine how to strengthen health systems so that they meet the individualized needs of clients with co-morbid diseases like hypertension [<span>7</span>], while also working with partner governments to determine opportunities for synergy and integration of HIV services into primary care systems.</p><p>Advancing PEPFAR's commitment to health equity while determining how and where to deploy new biomedical tools also raises a unique set of Programme Science questions [<span>8, 9</span>]. Decisions about the deployment of tools like long-acting HIV prevention and treatment must include consideration of context-specific factors, including end-user preferences [<span>10</span>], service delivery infrastructure [<span>11</span>] and resource availability.</p><p>Faced with these different and diverse challenges and opportunities, the new PEPFAR five-year strategic plan calls for an integration of science directly into programme planning and execution. Moreover, it will require a dynamic approach to how scientific insights are derived directly from programme experiences rather than only translating research into policy [<span>12</span>]. In the past, PEPFAR's policy decisions have often been guided by applying proven strategies from one context to another and leveraging existing hypothesis-driven science to inform planning, applying insights from science to policy and programmes. Notable examples include the introduction of the “Treatment as Prevention” strategy [<span>13</span>] and scaling pre-exposure prophylaxis interventions [<span>14</span>]. Policies for both were developed based on a substantial body of evidence that pre-existed policy formulation. However, this approach relied on scientific evidence being readily available to answer PEPFAR's strategic questions [<span>15</span>].</p><p>To realize the goals outlined in PEPFAR's strategic plan requires a shift in how programmes inform science and how and when science is used to shape its programmes. It demands that HIV programmes play a primary role in identifying how science is leveraged to close gaps in HIV service provision and to determine how best to scale new integrated service delivery models or potentially transformative biomedical tools. The focus needs to be on generating insights relevant to specific contexts that are also generalizable to different settings while prioritizing health equity.</p><p>Moving forward, PEPFAR is planning future initiatives across supported countries and regions to contribute to Programme Science, while also encouraging others working on the HIV response to expand their contributions to Programme Science too. PEPFAR's upcoming Country Operational Planning Guidance will highlight the importance of Programme Science for PEPFAR-supported country and regional programmes to prioritize in their operational planning process, aimed at addressing strategic priorities and programmatic gaps specific to each country or region. Incorporating Programme Science into operational planning, PEPFAR can better address identified gaps in knowledge and practice, ensuring that interventions are both scientifically grounded, pragmatically viable for diverse global contexts and responsive to local strategic priorities.</p><p>A critical next step involves empowering HIV programmes in each country in partnership with Ministries of Health, National Public Health Institutions, local academic partners and community leadership to identify the gaps where Programme Science can help ensure that evidence informs programmes on the timeline and at the scale necessary to drive impact. Creating the capacity to use Programme Science to inform strategic planning and resource allocation can ensure that programmes are continually responsive to the evolution of the HIV pandemic and that the needed biomedical and clinical tools, as well as essential resources, are available. Zambia offers a useful example of how this can work; a data hub run by the Ministry of Health with technical and limited financial support from PEPFAR is using rigorous analytic approaches to interrogate programme data to understand how and where programme improvements are likely to be most impactful. The Zambia example also illustrates how embedding Programme Science into how PEPFAR country programmes operate can also help advance PEPFAR's commitment to sustainable development, strengthened public health systems and transformative partnerships [<span>16</span>]. This approach not only addresses current challenges but also lays the groundwork for long-term success, ensuring that programmes continue to prioritize equity and impact.</p><p>As PEPFAR enters a new phase in its response to the HIV pandemic, it is important to ensure that policies and strategies are both evidence-based and tailored to the unique challenges of different communities and regions. As such, PEPFAR is committed to taking necessary steps to ensure that HIV programmes are empowered and have the capacity to undertake the kinds of analyses necessary for Programme Science to lead to programme improvement. We are explicitly designing new processes and mechanisms into our funding and policy guidance that foster the enabling environment for science and innovation necessary to accelerate progress. These changes can ensure that each country realizes the goal of 95-95-95 and that PEPFAR programmes continue to adapt to the evolving pandemic while also empowering the relevant local stakeholders to take the lead in using science to improve programmes.</p><p>The authors declare no competing interests.</p><p>RB and MJAR conceived of the presented idea. The first draft was written by MJAR, and all other authors revised and edited subsequent drafts. All authors reviewed the final, submitted draft.</p>\",\"PeriodicalId\":201,\"journal\":{\"name\":\"Journal of the International AIDS Society\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233845/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the International AIDS Society\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26244\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26244","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

要实现 PEPFAR 战略计划中概述的目标,需要改变计划为科学提供信息的方式,以及如何和何时利用科学来制定计划。这就要求艾滋病毒防治计划在确定如何利用科学来弥补艾滋病毒防治服务提供方面的差距,以及确定如何最好地推广新的综合服务提供模式或潜在的变革性生物医学工具方面发挥主要作用。今后,PEPFAR 将在受支持的国家和地区规划未来的计划,为计划科学做出贡献,同时也鼓励其他从事艾滋病防治工作的人员扩大对计划科学的贡献。PEPFAR 即将发布的《国家业务规划指南》将强调 "计划科学 "对于 PEPFAR 支持的国家和地区计划在其业务规划过程中优先考虑的重要性,旨在解决每个国家或地区特有的战略优先事项和计划差距。将计划科学纳入业务规划,PEPFAR 可以更好地弥补已确定的知识和实践差距,确保干预措施既有科学依据,在全球不同背景下切实可行,又能响应当地的战略优先事项。下一步的关键工作是,与各国卫生部、国家公共卫生机构、当地学术合作伙伴和社区领导层合作,增强各国艾滋病计划的能力,以确定计划科学在哪些方面可以帮助弥补差距,确保在必要的时间和规模上为计划提供证据信息,从而产生影响。建立利用计划科学为战略规划和资源分配提供信息的能力,可确保各项计划不断应对艾滋病毒流行病的演变,并确保提供所需的生物医学和临床工具以及基本资源。赞比亚提供了一个有用的范例,说明了这一方法如何发挥作用;卫生部在总统艾滋病紧急救援计划的技术和有限资金支持下管理的一个数据中心,正在使用严格的分析方法对计划数据进行分析,以了解如何以及在哪些方面改进计划最有可能产生影响。赞比亚的例子还说明,将 "计划科学 "纳入 PEPFAR 国家计划的运作方式,也有助于推动 PEPFAR 对可持续发展、加强公共卫生系统和变革性伙伴关系的承诺[16]。随着 PEPFAR 进入应对艾滋病毒大流行的新阶段,必须确保政策和战略既以证据为基础,又适合不同社区和地区的独特挑战。因此,"总统艾滋病紧急救援计划 "致力于采取必要步骤,确保艾滋病毒防治计划获得授权,并有能力开展计划科学所需的各类分析,从而改进计划。我们正在明确地在我们的供资和政策指导中设计新的流程和机制,为加快进展所需的科学和创新营造有利环境。这些变化可以确保每个国家都能实现 95-95-95 的目标,确保 PEPFAR 计划能够继续适应不断变化的流行病,同时赋予当地相关利益方权力,使其在利用科学改进计划方面发挥主导作用。第一稿由马约尔撰写,所有其他作者对随后的草稿进行了修改和编辑。所有作者都审阅了提交的最终草案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Programme Science in PEPFAR: a pathway to a sustainable HIV response

Since its inception, the President's Emergency Plan For AIDS Relief (PEPFAR) has had an unprecedented impact on the global HIV epidemic. In the past 20 years, PEPFAR has saved more than 25 million lives, supporting over 20 million people with life-saving treatment across 55 countries [1]. From the beginning, its programmes have relied on the best scientific insights and biomedical discoveries to advance the strategic HIV agenda. Moving forward, PEPFAR faces numerous important challenges in supporting partner countries to achieve the UNAIDS targets of ensuring that 95% of people with HIV know their status, 95% of those are on treatment and 95% of those are virologically suppressed [2], and achieving its goal of ending the HIV pandemic as a public health threat by 2030. As such, it is important to consider how Programme Science—an approach that emphasizes the need for context-specific evidence and knowledge generated on an ongoing basis, to inform the timely and strategic programmatic decisions [3, 4]—can help ensure that PEPFAR programmes implement the right set of context-specific interventions to achieve and sustain the changes essential for HIV prevention and treatment outcomes. In this paper, we detail (1) the evolving challenges and opportunities PEPFAR faces in achieving 95-95-95, (2) how Programme Science can be strategically applied to overcome these challenges, and (3) the necessary adaptations needed to sustain HIV programmes, informed by the best, contextually relevant science.

As PEPFAR and its partners intensify efforts to achieve the UNAIDS targets and sustain the progress achieved, they face a range of complex and urgent health challenges. Addressing these challenges requires a Programme Science approach that is responsive to diverse real-world contexts—be they geographical, organizational or sociological [5].

One of the most urgent challenges PEPFAR programmes face is reaching those populations that are not effectively covered by existing services. This is especially true in many countries with high HIV burden, where there is a pressing and urgent need to devise innovative approaches to engage adolescents and young women who are at inordinate risk of HIV acquisition. Equally important is the provision of targeted interventions for specific key and priority groups like men who have sex with men and female sex workers, who often face significant barriers in accessing health services due to stigma, discrimination, and legal and human rights issues.

Another critical area of focus is supporting continuity of care for people living with HIV who have been linked to HIV services. Across PEPFAR programmes, over 450,000 persons experienced interruptions in treatment at some point in the third quarter of 2023 [6]. As such, supporting clients to stay engaged in lifelong care necessitates the identification and implementation of a tailored mix of biomedical, behavioural and structural interventions to ensure the continued provision and uptake of HIV treatment services. These interventions must be adaptable to suit the diverse needs of different populations in various locations.

Additionally, HIV programme must address the system-level challenges necessary to ensure that existing HIV services have an enduring impact and are optimally integrated into government-run programmes. As such, programmes must determine how to strengthen health systems so that they meet the individualized needs of clients with co-morbid diseases like hypertension [7], while also working with partner governments to determine opportunities for synergy and integration of HIV services into primary care systems.

Advancing PEPFAR's commitment to health equity while determining how and where to deploy new biomedical tools also raises a unique set of Programme Science questions [8, 9]. Decisions about the deployment of tools like long-acting HIV prevention and treatment must include consideration of context-specific factors, including end-user preferences [10], service delivery infrastructure [11] and resource availability.

Faced with these different and diverse challenges and opportunities, the new PEPFAR five-year strategic plan calls for an integration of science directly into programme planning and execution. Moreover, it will require a dynamic approach to how scientific insights are derived directly from programme experiences rather than only translating research into policy [12]. In the past, PEPFAR's policy decisions have often been guided by applying proven strategies from one context to another and leveraging existing hypothesis-driven science to inform planning, applying insights from science to policy and programmes. Notable examples include the introduction of the “Treatment as Prevention” strategy [13] and scaling pre-exposure prophylaxis interventions [14]. Policies for both were developed based on a substantial body of evidence that pre-existed policy formulation. However, this approach relied on scientific evidence being readily available to answer PEPFAR's strategic questions [15].

To realize the goals outlined in PEPFAR's strategic plan requires a shift in how programmes inform science and how and when science is used to shape its programmes. It demands that HIV programmes play a primary role in identifying how science is leveraged to close gaps in HIV service provision and to determine how best to scale new integrated service delivery models or potentially transformative biomedical tools. The focus needs to be on generating insights relevant to specific contexts that are also generalizable to different settings while prioritizing health equity.

Moving forward, PEPFAR is planning future initiatives across supported countries and regions to contribute to Programme Science, while also encouraging others working on the HIV response to expand their contributions to Programme Science too. PEPFAR's upcoming Country Operational Planning Guidance will highlight the importance of Programme Science for PEPFAR-supported country and regional programmes to prioritize in their operational planning process, aimed at addressing strategic priorities and programmatic gaps specific to each country or region. Incorporating Programme Science into operational planning, PEPFAR can better address identified gaps in knowledge and practice, ensuring that interventions are both scientifically grounded, pragmatically viable for diverse global contexts and responsive to local strategic priorities.

A critical next step involves empowering HIV programmes in each country in partnership with Ministries of Health, National Public Health Institutions, local academic partners and community leadership to identify the gaps where Programme Science can help ensure that evidence informs programmes on the timeline and at the scale necessary to drive impact. Creating the capacity to use Programme Science to inform strategic planning and resource allocation can ensure that programmes are continually responsive to the evolution of the HIV pandemic and that the needed biomedical and clinical tools, as well as essential resources, are available. Zambia offers a useful example of how this can work; a data hub run by the Ministry of Health with technical and limited financial support from PEPFAR is using rigorous analytic approaches to interrogate programme data to understand how and where programme improvements are likely to be most impactful. The Zambia example also illustrates how embedding Programme Science into how PEPFAR country programmes operate can also help advance PEPFAR's commitment to sustainable development, strengthened public health systems and transformative partnerships [16]. This approach not only addresses current challenges but also lays the groundwork for long-term success, ensuring that programmes continue to prioritize equity and impact.

As PEPFAR enters a new phase in its response to the HIV pandemic, it is important to ensure that policies and strategies are both evidence-based and tailored to the unique challenges of different communities and regions. As such, PEPFAR is committed to taking necessary steps to ensure that HIV programmes are empowered and have the capacity to undertake the kinds of analyses necessary for Programme Science to lead to programme improvement. We are explicitly designing new processes and mechanisms into our funding and policy guidance that foster the enabling environment for science and innovation necessary to accelerate progress. These changes can ensure that each country realizes the goal of 95-95-95 and that PEPFAR programmes continue to adapt to the evolving pandemic while also empowering the relevant local stakeholders to take the lead in using science to improve programmes.

The authors declare no competing interests.

RB and MJAR conceived of the presented idea. The first draft was written by MJAR, and all other authors revised and edited subsequent drafts. All authors reviewed the final, submitted draft.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
期刊最新文献
Excess mortality attributable to AIDS among people living with HIV in high-income countries: a systematic review and meta-analysis Pre-exposure prophylaxis implementation gaps among people vulnerable to HIV acquisition: a cross-sectional analysis in two communities in western Kenya, 2021–2023 Issue Information Power, data and social accountability: defining a community-led monitoring model for strengthened health service delivery Very high HIV prevalence and incidence among men who have sex with men and transgender women in Indonesia: a retrospective observational cohort study in Bali and Jakarta, 2017–2020
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1